Advantium Actively Developing Novel Generation of Biofuel

During the visit of the Deputy Mayor of Amsterdam, Mr. Lodewijk Asscher, Avantium has announced that it is active in developing a novel generation of biofuels.

The Deputy Mayor of Amsterdam, Lodewijk Asscher, said: "The city of Amsterdam is delighted with the progress of Avantium. Avantium is a fast growing and highly innovative company with large potential for our city".

Tom van Aken, Chief Executive Officer of Avantium, said: " We are very proud to be able to undertake break-through R&D in the area of renewable energy This illustrates the success of our strategy to develop new products on the basis of our unique technology."

Biofuels are transportation fuels derived from biomass, such as sugars. They are a sustainable alternative for fossil based fuels such as gasoline and diesel. In 2006, Avantium started with a research program to develop biofuels with improved properties compared to the current generation of biofuels, in order to increase the mileage per liter. To be able to efficiently produce this new generation of biofuels, the company has focused on chemically catalyzed processes rather than on fermentation based production methods. In the next phase, Avantium will produce larger volumes of these novel biofuels and run engine tests.

The ultimate goal is to develop and commercialize these novel products through partnerships with leading industrial companies in the field.

During the visit, the Flowrence research platform was also presented. The Flowrence is a parallel reactor system for testing catalysts, the result of 7 years development by Avantium. Avantium has developed a customized Flowrence for its biofuels development program. This Flowrence unit, which will further accelerate the Avantium research program, had a central position in today's festivities.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.